Science Explorer Back to mapMap
Discussion
Researcher · Ludwig-Maximilians-Universität München · Germany

Stefanos Michaelides

Stefanos Michaelides publishes mostly in Oncology, Immunology and Radiology, Nuclear Medicine and Imaging, on topics such as CAR-T cell therapy research, Immune Cell Function and Interaction and Monoclonal and Polyclonal Antibodies Research.

ORCID 0000-0002-9001-0207 OpenAlex
World rank
#2,495,623
of 7,710,434 ranked researchers
Rank in Germany
#123,482
of 364,343
Works
16
Citations
393
Citations per work
24.6
h-index
8
i10-index 7Top 72% in Oncology
Stefanos Michaelides

What does Stefanos Michaelides research?

Stefanos Michaelides's work is mostly in Medicine (49%), Immunology and Microbiology (29%), Biochemistry, Genetics and Molecular Biology (11%).

Health Sciences: 8 works · 48.9% of their workMedicine: 8 works · 48.9% of their workOncology: 6 works · 37.8% of their workRadiology, Nuclear Medicine and Imaging: 2 works · 11.1% of their workLife Sciences: 6 works · 40.0% of their workImmunology and Microbiology: 5 works · 28.9% of their workImmunology: 5 works · 28.9% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 11.1% of their workMolecular Biology: 1 works · 6.7% of their workGenetics: 1 works · 4.4% of their workEverything else: 1 works · 8.9% of their workPhysical Sciences: 0 works · 2.2% of their workEngineering: 0 works · 2.2% of their workComputational Mechanics: 0 works · 2.2% of their workTHEIR WORKStefanosMichaelides16works
Life Sciences40%Physical Sciences2%Health Sciences49%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine848.9%
    1. Immunology and Microbiology528.9%
    2. Biochemistry, Genetics and Molecular Biology211.1%
  3. Everything else18.9%
    1. Engineering02.2%
  1. 1Oncology38% of their works
  2. 2Immunology29% of their works
  3. 3Radiology, Nuclear Medicine and Imaging11% of their works
  4. 4Molecular Biology7% of their works
  5. 5Genetics4% of their works
  6. 6Computational Mechanics2% of their works

Research topics

Which keywords describe Stefanos Michaelides's research?

The keywords of their largest research topics: Cancer Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, Glycosylation, Natural Killer Cells, NK Cell Recognition, Fc Receptors and Therapeutic Antibodies.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Cancer Immunotherapy172 topics
  2. CAR T Cells131 topic
  3. Chimeric Antigen Receptor131 topic
  4. Glycosylation72 topics
  5. NK Cell Recognition61 topic
  6. Natural Killer Cells61 topic
  7. Fc Receptors51 topic
  8. Therapeutic Antibodies51 topic
  9. Dendritic Cells41 topic
  10. Immune Checkpoint Blockade41 topic
  11. Immunity41 topic
  12. PD-1 and PD-L141 topic
  13. Foxp321 topic
  14. Gene Therapy21 topic
  15. Mammalian Cells21 topic
  16. Recombinant Protein21 topic
  17. TGF-ß21 topic
  18. Viral Vectors21 topic

Where does Stefanos Michaelides work?

Stefanos Michaelides's main affiliation in the publication record is Ludwig-Maximilians-Universität München, Germany.

How many publications and citations does Stefanos Michaelides have?

OpenAlex counts 16 works and 393 citations for Stefanos Michaelides, an h-index of 8, ranking #2,495,623 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Stefanos Michaelides. Posts are plain text and can be reported.